These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16192611)

  • 21. [Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years].
    Santo A; Genestreti G; Fiorio E; Terzi A; Lonardoni A; Calabrò F; Campaldini B; Colaluca P; Molino A; Cetto GL
    Recenti Prog Med; 2006 Apr; 97(4):211-8. PubMed ID: 16729492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxaliplatin doublets in non-small cell lung cancer: a literature review.
    Cortinovis D; Bidoli P; Zilembo N; Fusi A; Bajetta E
    Lung Cancer; 2008 Jun; 60(3):325-31. PubMed ID: 18440088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
    J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II.
    Blumenschein GR; Khuri FR; von Pawel J; Gatzemeier U; Miller WH; Jotte RM; Le Treut J; Sun SL; Zhang JK; Dziewanowska ZE; Negro-Vilar A
    J Clin Oncol; 2008 Apr; 26(11):1879-85. PubMed ID: 18398153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of combination chemotherapy with mitomycin and vinorelbine for the treatment of advanced non-small cell lung cancer.
    Wibmer T; Kropf C; Merk T; Schumann C; Hombach V; Krüger S
    Lung Cancer; 2008 May; 60(2):231-9. PubMed ID: 18006111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer.
    Zhang Z; Xu F; Wang S; Li N; Wang C
    Lung Cancer; 2008 Jun; 60(3):434-40. PubMed ID: 18036699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue.
    Petrelli F; Ghilardi M; Cremonesi M; Cabiddu M; Barni S
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1455-65. PubMed ID: 19828007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.
    Jennens RR; Giles GG; Fox RM
    Intern Med J; 2006 Apr; 36(4):216-20. PubMed ID: 16640737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multimodal therapy of small cell and non-small cell lung carcinoma].
    Serke M; Kollmeier J
    Dtsch Med Wochenschr; 2007 Jun; 132(22):1221-4. PubMed ID: 17520508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemotherapy for advanced non-small-cell lung cancer: combinations without platinium derivatives].
    Pujol JL
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S17-4S19. PubMed ID: 15687988
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemotherapy for advanced lung cancer.
    Blackhall F; Thatcher N
    Eur J Cancer; 2004 Nov; 40(16):2345-8. PubMed ID: 15519503
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making process.
    De Pas T; de Braud F; Veronesi G
    J Thorac Oncol; 2010 May; 5(5):754. PubMed ID: 20421773
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemotherapy for non-small-cell lung cancer.
    van Meerbeeck JP; Legrand C; van Klaveren RJ; Giaccone G;
    Lancet; 2001 Oct; 358(9289):1271-2. PubMed ID: 11675091
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chemotherapy of advanced non-small cell carcinoma of the lung].
    Radosavljević D; Jelić S; Popov I; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1999; 127(3-4):142-8. PubMed ID: 10500439
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytotoxic chemotherapy in advanced non-small cell lung cancer.
    Scagliotti GV; Novello S; Selvaggi G
    Monaldi Arch Chest Dis; 2005 Dec; 63(4):181-3. PubMed ID: 16454216
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of performance status 2 patients with advanced non-small-cell lung cancer: what we know and what we don't know.
    Tartarone A; Aieta M
    Future Oncol; 2009 Aug; 5(6):837-41. PubMed ID: 19663733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-small cell lung cancer: second-line and beyond.
    Stahel RA
    Ann Oncol; 2006 Sep; 17 Suppl 10():x97-100. PubMed ID: 17018760
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors contributing to adjuvant therapy decisions.
    Howe KL; Leighl NB
    J Thorac Oncol; 2008 Feb; 3(2):195-6. PubMed ID: 18303445
    [No Abstract]   [Full Text] [Related]  

  • 39. How to combine cytotoxic and cytostatic agents.
    Gridelli C
    Lung Cancer; 2002 Oct; 38(1):S39-40. PubMed ID: 12367813
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment perspectives in advanced non-small cell lung cancer.
    Soto Parra H; Latteri F; Cavina R; Sala A; Dambrosio M; Alloisio M; Santoro A
    Tumori; 2000; 86(5 Suppl 1):S36-41. PubMed ID: 11195292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.